nakajima yuto 中島由翔

… Alternative Names

NAKAJIMA YUTO 中島由翔

Less

Researcher Number	00905408
Other IDs	https://orcid.org/0000-0001-5422-2782
Affiliation (Current)	2026: 奈良県立医科大学, 医学部, 助教 2026: 奈良県立医科大学, 医学部附属病院, 研究員
Affiliation (based on the past Project Information) *help	2022 – 2025: 奈良県立医科大学, 医学部附属病院, 研究員 2024: 奈良県立医科大学, 医学部附属病院, 助教
Review Section/Research Field	Principal Investigator Basic Section 52050:Embryonic medicine and pediatrics-related
Keywords	Principal Investigator 遺伝子治療 / 高機能型第VIII因子 / 血友病A / 高機能型FVIII

Research Projects
(2 results)
Research Products
(6 results)

血友病Aにおける高機能型第VIII因子製剤開発の基礎研究Principal Investigator
- Principal Investigator
  
  中島由翔
- Project Period (FY)
  2025 – 2027
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 52050:Embryonic medicine and pediatrics-related
- Research Institution
  Nara Medical University
Development of gain-of-function Factor VIII Products for the Treatment of Hemophilia APrincipal Investigator
- Principal Investigator
  
  NAKAJIMA YUTO
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 52050:Embryonic medicine and pediatrics-related
- Research Institution
  Nara Medical University

All 2024 2023 2022

All Journal Article Presentation

[Journal Article] The combination of Asp519Val/Glu665Val and Lys1813Ala mutations in FVIII markedly increases coagulation potential2024
- Author(s)
  Nakajima Yuto、Oda Akihisa、Baatartsogt Nemekhbayar、Kashiwakura Yuji、Ohmori Tsukasa、Nogami Keiji
- Journal Title
  
  Blood Advances
  
  Volume: 8 Issue: 15 Pages: 3929-3940
- DOI
  10.1182/bloodadvances.2023012391
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K15928, KAKENHI-PROJECT-24K10935, KAKENHI-PROJECT-24K11028
[Journal Article] Factor VIII mutated with Lys1813Ala within the factor IXa-binding region enhances intrinsic coagulation potential.2023
- Author(s)
  Nakajima Y, Takeyama M, Oda A, Shimonishi N, Nogami K.
- Journal Title
  
  Blood Advances
  
  Volume: 7 Issue: 8 Pages: 14361445-14361445
- DOI
  10.1182/bloodadvances.2022008187
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K15928, KAKENHI-PROJECT-21K07804, KAKENHI-PROJECT-21K07825
[Presentation] FVIII mutated with D519V/E665V/K1813A enhances coagulation potentials by high affinity for FIXa and stabilizing A2 domain2024
- Author(s)
  Yuto Nakajima
- Organizer
  ISTH 2024
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K15928
[Presentation] FVIII mutated with D519V/E665V/K1813A enhances coagulation potentials by stabilizing A2 domain2023
- Author(s)
  Yuto Nakajima, Akihisa Oda, Keiji Nogami
- Organizer
  第85回日本血液学会
- Data Source
  KAKENHI-PROJECT-22K15928
[Presentation] FVIII mutated with Lys1813Ala within the FIXa-binding region enhances coagulation potentials2022
- Author(s)
  Yuto Nakajima, Masahiro Takeyama, Akihisa Oda, Keiji Nogami
- Organizer
  第84回日本血液学会
- Data Source
  KAKENHI-PROJECT-22K15928
[Presentation] Factor VIII K1813A which has high affinity for activated factor IX enhances global coagulation function2022
- Author(s)
  Yuto Nakajima, Masahiro Takeyama, Akihisa Oda, Keiji Nogami
- Organizer
  International Society on Thrombosis and Haemostasis
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K15928

nakajima yuto 中島 由翔

NAKAJIMA YUTO 中島 由翔

Research Projects

Research Products

血友病Aにおける高機能型第VIII因子製剤開発の基礎研究Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of gain-of-function Factor VIII Products for the Treatment of Hemophilia APrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] The combination of Asp519Val/Glu665Val and Lys1813Ala mutations in FVIII markedly increases coagulation potential2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Factor VIII mutated with Lys1813Ala within the factor IXa-binding region enhances intrinsic coagulation potential.2023

Author(s)

Journal Title

DOI

Data Source

[Presentation] FVIII mutated with D519V/E665V/K1813A enhances coagulation potentials by high affinity for FIXa and stabilizing A2 domain2024

Author(s)

Organizer

Data Source

[Presentation] FVIII mutated with D519V/E665V/K1813A enhances coagulation potentials by stabilizing A2 domain2023

Author(s)

Organizer

Data Source

[Presentation] FVIII mutated with Lys1813Ala within the FIXa-binding region enhances coagulation potentials2022

Author(s)

Organizer

Data Source

[Presentation] Factor VIII K1813A which has high affinity for activated factor IX enhances global coagulation function2022

Author(s)

Organizer

Data Source

nakajima yuto 中島由翔

NAKAJIMA YUTO 中島由翔